Team:Paris Bettencourt/Notebook/Trojan Horse/Friday 28th June

From 2013.igem.org

(Difference between revisions)
Line 1: Line 1:
-
 
<div id"container">
<div id"container">
<div id="noteimg">
<div id="noteimg">
 +
<html>
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Trojan_Horse">
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Trojan_Horse">
<img src="https://static.igem.org/mediawiki/2013/0/00/PB_Trojan_Horse_logo.png" height="30px" width="30px">
<img src="https://static.igem.org/mediawiki/2013/0/00/PB_Trojan_Horse_logo.png" height="30px" width="30px">
-
</a></div>
+
</a></html>
 +
</div>
<div id="notetwit">
<div id="notetwit">
 +
<html>
<b> Add here your twit </b></br>
<b> Add here your twit </b></br>
 +
</html>
</div><div class"clear"></div></div>
</div><div class"clear"></div></div>
<div >
<div >

Revision as of 09:31, 29 July 2013

Add here your twit

sRNA design

sRNA Design

Red sequences:

pACYCDuet-1 (CmR) : ATATCCAGTGATTTTTTTCTCCAT
pCOLADuet-1 (KanR) : CGTTTCCCGTTGAATATGGCTCAT

We decided that targeting only two different antibiotic resistance will be enough for a proof of concept. We give up AmpR because otherwise they might be experimental issues with AmpR that is also on phagemid litmus28i.